Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-10-23
|
pubmed:abstractText |
To investigate the role of nitric oxide (NO) with respect to kidney function and liver cirrhosis, we evaluated renal function, as well as cyclic guanosine monophosphate (cGMP) and NOx (nitrite/nitrate [NO3-/NO2-]) as indirect markers of NO formation in plasma and urine at rest and during amino acid (aa)-induced glomerular hyperfiltration in patients with Child A liver cirrhosis and portal hypertension (n = 12), and in healthy controls (n = 10). Baseline filtration rate (GFR) and effective renal plasma flow (ERPF) were significantly lower in patients with cirrhosis than in controls (GFR: mean 88 +/- SD 16 mL/min vs. 106 +/- 15 mL/min, P = .01, ERPF: 477 +/- 93 vs. 561 +/- 72 mL/min, P = .002). In both groups amino acid (aa) infusion increased GFR, ERPF, as well as cGMP and urinary NOx. Changes in GFR were similar in cirrhotic patients and controls (28.3% +/- 14% in cirrhotics and 26% +/- 11% in controls), but the degree of aa-induced changes in ERPF was more marked in patients with liver cirrhosis (31.8% +/- 17% vs. 18.6% +/- 12%, P = .02). Plasma levels of NOx and cGMP were similar in either group at baseline and during aa infusion, whereas NOx and cGMP excretion in cirrhotics was constantly 14% to 24% lower than in the control group. We conclude that patients with compensated liver cirrhosis and portal hypertension already have an impaired kidney function. In addition our data suggest a cirrhosis-related dissociation between ERPF and GFR during aa stimulation. Further studies are warranted to find out whether a local imbalance between vasoconstrictors and vasodilators, e.g., decreased local NO formation, plays a key role for this phenomenon.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
858-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9328305-Adult,
pubmed-meshheading:9328305-Aged,
pubmed-meshheading:9328305-Aldosterone,
pubmed-meshheading:9328305-Blood Pressure,
pubmed-meshheading:9328305-Female,
pubmed-meshheading:9328305-Glomerular Filtration Rate,
pubmed-meshheading:9328305-Heart Rate,
pubmed-meshheading:9328305-Humans,
pubmed-meshheading:9328305-Kidney,
pubmed-meshheading:9328305-Liver Cirrhosis,
pubmed-meshheading:9328305-Male,
pubmed-meshheading:9328305-Middle Aged,
pubmed-meshheading:9328305-Nitric Oxide,
pubmed-meshheading:9328305-Renal Circulation,
pubmed-meshheading:9328305-Renin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
|
pubmed:affiliation |
Department of General Internal Medicine, University of Bonn, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|